Clik here to view.
Cigna Launches Brand Campaign for International Markets Based on Real Stories...
HONG KONG Cigna has unveiled its first ever regional brand campaign for key international markets, designed to showcase the company’s capabilities and the solutions it delivers for customers. The...
View ArticleClik here to view.
Clik here to view.
Chugai and Galderma Announce Global License Agreement for Nemolizumab...
TOKYO & LAUSANNE, Switzerland Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Galderma Pharma S.A. today announced that they have entered into a global license agreement for “nemolizumab”...
View ArticleClik here to view.
Starpharma Signs License for a VivaGel® Condom in China
MELBOURNE, Australia Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) today announced the signing of an exclusive license and supply agreement with Shenyang Sky and Land Latex Co. Ltd. (Sky and Land)...
View ArticleClik here to view.
Seattle Genetics与武田宣布，《血液》杂志发表ADCETRIS® (Brentuximab...
华盛顿州博瑟尔、马萨诸塞州剑桥和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (NASDAQ:SGEN)与武田药品工业株式会社(TSE:4502)今天宣布，《血液》杂志发表ADCETRIS (brentuximab...
View ArticleClik here to view.
MTPConnect Unveils 10-Year Plan to Boost Competitiveness of Medtech, Biotech...
MELBOURNE, Australia MTPConnect – The Medical Technologies and Pharmaceuticals Industry Growth Centre – today launched its Draft Sector Competitiveness Plan (Draft SCP), a 10-year strategic plan to...
View ArticleClik here to view.
Starpharma签署VivaGel®避孕套在中国的授权
澳大利亚墨尔本 (美国商业资讯) — 澳大利亚生物科技公司Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) 七月二十一日宣布，与沈阳天地乳胶有限公司（天地公司）签署排他性授权和供货协议，面向中国避孕套市场的政府细分市场生产和销售VivaGel®避孕套。该协议之前，Starpharma于2015年12月与天地公司签署了谅解备忘录。...
View ArticleClik here to view.
Octapharma将在美国奥兰多召开的世界血友病联盟(WFH) 2016年世界大会期间赞助两场研讨会
瑞士拉亨 (美国商业资讯) — Octapharma将在美国奥兰多召开的WFH 2016年世界大会期间赞助一系列活动，包括两场研讨会以及若干介绍Octapharma在血友病A和血管性血友病(VWD)领域近期进展的壁报和科学呈报。 首场研讨会“复杂问题的简单解决方案：应对当今的VWD和血友病A挑战”将于2016年7月25日星期一召开，由瑞典马尔默隆德大学Erik...
View ArticleClik here to view.
CANbridge’s CAN-008 Approved for Phase I/II Trial in Newly-Diagnosed...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that the Taiwan Food and Drug Administration (TFDA) has...
View ArticleClik here to view.
Dr. Reddy’s Q1 FY17 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY): Revenues at Rs. 32.3 billion (YoY decline of 14%) EBITDA at Rs. 4.0 billion (12.3% of the revenues)...
View ArticleClik here to view.
Growth of DCAT Week Spurs Expansion of Annual Event’s NYC Meeting Space
ROBBINSVILLE, N.J. Due to the significant increase in attendance and opportunities for updated business meeting space, the Drug, Chemical & Associated Technologies Association (DCAT) announced...
View ArticleClik here to view.
ASLAN Pharmaceuticals Enters Service Agreement with Selexis SA for...
GENEVA & SINGAPORE Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, and ASLAN Pharmaceuticals, a biotech company...
View ArticleClik here to view.
Chugai’s Emicizumab Showed Continued Benefits in Patients with Hemophilia A
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that latest data from an ongoing Japanese Phase I/II study (ACE002JP) of emicizumab was presented at the World Federation of...
View ArticleClik here to view.
オクタファルマ、米オーランドで開催の世界血友病連盟（WFH）2016年世界大会で2件のシンポジウムを後援
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマは米国のオーランドで開催される今年のWFH世界大会にて、血友病Aとフォン・ヴィルブランド病（VWD）におけるオクタファルマの最近の成果を取り上げた2件のシンポジウムならびに数多くのポスターおよび学術発表を含め、さまざまな活動を後援します。...
View ArticleClik here to view.
Orthofix Announces Japanese Approval and Market Launch of PHOENIX Minimally...
LEWISVILLE, Texas Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare...
View ArticleClik here to view.
Gland Pharma to be Acquired by Fosun Pharma
HYDERABAD Gland Pharma Limited (“Gland” or “The Company”), a leading Indian pure-play generic injectable pharmaceutical products company, today announced the signing of a definitive agreement under...
View ArticleClik here to view.
Acelity to Offer New Gelling Fiber Advanced Wound Dressing
SAN ANTONIO Acelity, a global advanced wound care and regenerative medicine company, announced today that BIOSORB™ Gelling Fiber Dressing is now available in the United States and has Conformité...
View ArticleClik here to view.
Second Sight Announces Two Exclusive Distribution Agreements to Bring the...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful...
View ArticleClik here to view.